首页> 外文期刊>Oral oncology >Comments on ''Geranylgeraniol--a new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw' by Ziebart T et al. (2011).
【24h】

Comments on ''Geranylgeraniol--a new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw' by Ziebart T et al. (2011).

机译:Ziebart T等人(2011)对``Geranylgeraniol-一种新的潜在的双膦酸酯相关性颌骨坏死性治疗方法''的评论。

获取原文
获取原文并翻译 | 示例
           

摘要

We read the article "Geranylgeraniol - A new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw" in Oral Oncology, by Ziebart T et al., and would like to compare and discuss these results with our recently published data.The design of the two studies is very similar: natural isopre-noids have been used to revert the mevalonate pathway inhibition induced by amino-bisphosphonates (N-BPs). Isoprenoid compounds are hypothesized to enter the mevalonate pathway after the N-BPs block, being metabolized as farnesyl-pyrophosphate and bypass the biochemical inhibition mediate by N-BPs on farnesyl-pyrophosphate synthase, restoring the metabolites flux along the pathway.
机译:我们阅读了Ziebart T等人在《口腔肿瘤学》上发表的文章“ Geranylgeraniol-一种新的治疗双膦酸酯相关性颌骨坏死的潜在治疗方法”,并希望将这些结果与我们最近发表的数据进行比较和讨论。两项研究非常相似:天然异戊二烯已用于恢复由氨基双膦酸酯(N-BPs)诱导的甲羟戊酸途径的抑制作用。假设类异戊二烯化合物在N-BP阻断后进入甲羟戊酸途径,被代谢为法呢基-焦磷酸,并绕过N-BP在法呢基-焦磷酸合酶上的生化抑制作用,恢复了沿途径的代谢物通量。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号